A ketogenic diet that includes meat, fish, vegetables, and beans is becoming increasingly popular, and it can also reduce the risk of metabolic syndrome and cancer, according to a new study.
The new research published in the Journal of the American Medical Association looked at more than 9,000 women who had been taking statins for more than a decade.
The researchers found that the women who were taking the statins, or the more popular statin-lowering statin combination, experienced a significant reduction in the risk for heart disease and stroke, as well as the overall risk of diabetes and cancer.
Researchers from the University of Michigan and the University at Buffalo also found that a low-fodMAP ketogenic ketogenic low carb diet can lower cholesterol and triglycerides, as reported by the Associated Press.
Researchers also found the ketogenic diets lower blood pressure, which is known to reduce the amount of cholesterol in the blood.
Researchers said that a diet with a low fODMAP (good for all of us) ratio, or protein and carbohydrates with the same amount of calories, may be a more beneficial approach to managing chronic conditions, such as diabetes and heart disease.
“Ketogenic diets have been shown to be beneficial for people with diabetes and may be an effective treatment for many chronic conditions,” said Dr. Richard G. Pfeifer, an assistant professor of medicine at the University At Buffalo.
“In people who are obese or have metabolic syndrome, low fos, or high LDL cholesterol, a low fat diet may be beneficial, as it reduces triglycerides and may reduce the need for insulin, as the body’s natural production of insulin increases with obesity and metabolic syndrome.”
Researchers also said that low-fat ketogenic and low-carbohydrate diets are also effective for weight loss.
“We recommend that people with metabolic syndrome or obesity avoid the high fat, low carbohydrate diets that have been recommended for weight management for over a decade,” said lead author of the study Dr. David T. Miller.
“These diets may be associated with a greater risk of type 2 diabetes and cardiovascular disease, which may be more prevalent in those who are overweight or obese.”
Dr. Miller said the results of the research were “very encouraging.”
The research found that people who were on statins experienced a 40 percent reduction in their risk for type 2 diabetics.
However, there was no statistically significant reduction with low- or moderate-fat diet alone.
Low-fat diets are often suggested to be a better option for people who have metabolic issues.
The research also showed that the keto diets lower LDL cholesterol by as much as 30 percent, as compared to high-fat and low carb diets.
Researchers are not sure how high a fodmaps ratio a person should be on to benefit from a low carb or keto low carb ketogenic lifestyle.
“Low-carb diets tend to be lower in calories and higher in carbs, whereas low-FODMAP diets tend not to have the same number of calories,” Miller said.
“It is important to know that low carb is not necessarily better than keto.
The benefits of keto will vary depending on your metabolic profile and overall health.”
He said that the researchers were interested in learning more about the effects of different diets on heart disease risk factors, such diabetes, obesity, and cholesterol.
The findings are in line with previous research that suggested the ketone body may be protective against atherosclerosis.
“This is the first randomized controlled trial to compare low- and moderate-carb, low-FA, and high-FA diets,” Miller noted.
“Both high- and low FA diets lowered LDL cholesterol levels in the diet-induced obese mice.”
“The results of this study suggest that ketogenic high-carb and low fat diets may help decrease the risk associated with metabolic disease, including metabolic syndrome,” said Tanya S. Rauch, a professor of clinical nutrition and epidemiology at the Kellogg School of Nutrition and Dietetics at Baylor College of Medicine.
“Although we are still studying the mechanisms of how low-Fat ketogenic can reduce LDL cholesterol and improve insulin sensitivity, we know it is beneficial for many people with these conditions.
Our hope is that other researchers will take the same approach and apply this information to patients and families.”